Replies to post #690094 on NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

Its possible, anything is possible. To me it just looks like she has a plan to merge with her other company and then form partnerships. In the long run, probably more profitable than a buyout. In 2028, I believe, nwbo will have sole authority over keytruda/dc-vax combo. The silence, building up manufacturing, the renewal classification of her other company(also a key combo partner), does not point to a buyout to me, at least not of NWBO. Now a buyout of a new combined company, manufacturing in place, approval in place, patents in place, that would be a hefty price tag. Either way, we will have a clearer idea sometime this year.